Stenting Seldom Done for Left Main Disease - MedPage Today
Posted by admin / Under Ortho McNeil Pharmaceutical
Stenting Seldom Done for Left Main Disease MedPage Today That risk was lower among those who received drug-eluting stents instead of bare metal stents (inverse probability weighted HR 0.84, 95% CI 0.73 to 0.96). "These results emphasize the need for a well-powered randomized clinical trial examining the ... |
Published on Tuesday 7th of February 2012 09:49:04 PM
Orexo announces termination of OX-CLI and OX-ESI programs - Pharmaceutical Business Review
Posted by admin / Under Ortho McNeil Pharmaceutical
Orexo announces termination of OX-CLI and OX-ESI programs Pharmaceutical Business Review Orexo and Janssen Pharmaceuticals, formerly Ortho-McNeil-Janssen Pharmaceuticals, and Janssen Pharmaceutica, have terminated their research collaboration and license agreement regarding the OX-CLI and OX-ESI programs. A third, undisclosed Janssen ... Orexo's drug discovery collaboration terminated and OX-CLI/OX-ESI projects end |
Published on Tuesday 7th of February 2012 09:49:04 PM
Johnson & Johnson Wins Jury Verdict Over Levaquin Warning - BusinessWeek
Posted by admin / Under Ortho McNeil Pharmaceutical
Johnson & Johnson Wins Jury Verdict Over Levaquin Warning BusinessWeek Clifford Straka, who blew out two Achilles tendons after taking the drug for pneumonia, sued J&J and its Ortho-McNeil Pharmaceutical unit in 2008. Straka said his doctor wasn't aware when she prescribed the drug that Levaquin was linked to an increased ... |
Published on Tuesday 7th of February 2012 09:49:04 PM
J&J Unit Didn't Hide Levaquin Health Risks, Company Lawyer Says at Trial - Bloomberg
Posted by admin / Under Ortho McNeil Pharmaceutical
J&J Unit Didn't Hide Levaquin Health Risks, Company Lawyer Says at Trial Bloomberg Clifford Straka, who blew out two Achilles tendons after taking the drug for pneumonia, sued J&J and its Ortho-McNeil Pharmaceutical unit in 2008. Straka said his doctor wasn't aware when she prescribed the drug that Levaquin was linked to an increased ... |
Published on Tuesday 7th of February 2012 09:49:04 PM
Dendreon Announces CEO and Chairman Succession Plan - MarketWatch (press release)
Posted by admin / Under Ortho McNeil Pharmaceutical
Dendreon Announces CEO and Chairman Succession Plan MarketWatch (press release) He joined Johnson & Johnson in 1988 and advanced through positions of increasing responsibility with Ortho-McNeil. In 2000, he served as president and chief executive officer for Parkstone Medical Information Systems. Mr. Johnson returned to Johnson ... |
Published on Tuesday 7th of February 2012 09:49:04 PM
NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for ... - Business Wire (press release)
Posted by admin / Under Ortho McNeil Pharmaceutical
NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for ... Business Wire (press release) NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, GlaxoSmithKline, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical. “NPS,” “NPS Pharmaceuticals ... |
Published on Tuesday 7th of February 2012 09:49:04 PM
US religious groups outraged over law on contraception - CTV.ca
Posted by admin / Under Ortho McNeil Pharmaceutical
 CTV.ca | US religious groups outraged over law on contraception CTV.ca A new birth control pill container designed to look like a woman's makeup compact for Ortho-McNeil Pharmaceutical Inc., of Raritan, NJ, is displayed at the manufacturer's assembly line May 28, 1999. (AP Photo/Mike Derer) The Associated Press The Obama ... |
Published on Tuesday 7th of February 2012 09:49:04 PM
Share this!